StockData
Regencell Bioscience Holdings Ltd logo

Regencell Bioscience Holdings Ltd (RGC) stock

RGCNasdaqMedicinal Chemicals & Botanical Products
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Oct 7, 2026Score 5/30
$4.55−0.17 (-3.60%)

Close on Nov 17, 2026Market cap $2.26BP/E –Yield –

Regencell Bioscience total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Regencell Bioscience

Regencell Bioscience has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Regencell Bioscience figures

See a number that looks wrong?